Cargando…

P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL

Detalles Bibliográficos
Autores principales: Rodríguez-Otero, P, Shah, N, Munshi, N, Berdeja, J, Jagannath, S, Finney, O, Martin, N, Agarwal, A, Rowe, E, Campbell, T, San-Miguel, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011718/
http://dx.doi.org/10.1097/01.HS9.0000829648.85784.e2